CLINICAL_TRIALS
trial_result
· 2018-01-30
Clinical Trial Update: Clinical Study to Evaluate the Effects of Macitentan on Exercise Capacity in Subjects With Eisenmenger Syndrome [Phase 3]
Summary
Phase 3 trial evaluating the effects of macitentan on exercise capacity in Eisenmenger syndrome completed with posted results in 2018.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Actelion | Conditions: Pulmonary Arterial Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2018-01-30